San Diego California based Angiocrine Bioscience is raising $99,372,730.00 in New Equity Investment.
San Diego, CA – According to filings with the U.S. Securities and Exchange Commission, Angiocrine Bioscience is raising $99,372,730.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Paul Finnegan played…